Literature DB >> 7860148

Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas.

R E Meyn1, L C Stephens, N R Hunter, L Milas.   

Abstract

There is mounting evidence to indicate that the mode of cell death known as apoptosis plays an important role in cancer therapy. Most supporting observations have come from experiments conducted in vitro, and it is important to extend such studies to in vivo systems. We have therefore evaluated the magnitude and kinetics of apoptosis induction in tumors from mice treated with cisplatin (CP). Two transplantable murine tumors were studied: a mammary adenocarcinoma, MCa-4, and an ovarian adenocarcinoma, OCa-1. Tumor-bearing mice were injected with various doses of CP, and specimens were obtained over several days. Apoptosis was scored by morphometric analysis of histological sections of the tumors using the features characteristic of cells undergoing this mode of cell death. The results showed a significant apoptotic response in both tumors within a few hours after injection of the drug. The kinetics were very broad, with apoptotic cells present over essentially the entire time course studied. Dose-response relationships for CP-induced apoptosis were compared to the tumor response measured in terms of tumor growth delay.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860148     DOI: 10.1002/ijc.2910600526

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Difference in expression of Bcl-2 and Bcl-xl genes in cisplatin-sensitive and cisplatin-resistant human in ovarian cancer cell lines.

Authors:  Lili Yu; Zehua Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

2.  MiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2.

Authors:  Jing Tian; Yan-Ying Xu; Lian Li; Quan Hao
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

3.  Superhelical torsion controls DNA interstrand cross-linking by antitumor cis- diamminedichloroplatinum(II).

Authors:  O Vrána; V Boudný; V Brabec
Journal:  Nucleic Acids Res       Date:  1996-10-15       Impact factor: 16.971

Review 4.  Programmed cell death and radioresistance.

Authors:  R E Meyn; L C Stephens; L Milas
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

5.  Chronic low vitamin intake potentiates cisplatin-induced intestinal epithelial cell apoptosis in WNIN rats.

Authors:  Bodiga Vijayalakshmi; Boindala Sesikeran; Putcha Udaykumar; Subramaniam Kalyanasundaram; Manchala Raghunath
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

6.  Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors.

Authors:  Hiroaki Kurihara; David J Yang; Massimo Cristofanilli; William D Erwin; Dong-Fang Yu; Saady Kohanim; Richard Mendez; E Edmund Kim
Journal:  Appl Radiat Isot       Date:  2008-01-26       Impact factor: 1.513

7.  Mistiming Death: Modeling the Time-Domain Variability of Tumor Apoptosis and Implications for Molecular Imaging of Cell Death.

Authors:  Seth T Gammon; Brian J Engel; Gregory J Gores; Erik Cressman; David Piwnica-Worms; Steven W Millward
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

8.  Systemic mesenchymal stem cells reduce growth rate of cisplatin-resistant ovarian cancer.

Authors:  Pengfei Zhu; Mo Chen; Li Wang; Yanxia Ning; Jie Liang; Hao Zhang; Congjian Xu; Sifeng Chen; Liangqing Yao
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

9.  The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells.

Authors:  Zhi Jiang; Bao-An Chen; Guo-Hua Xia; Qiang Wu; Yu Zhang; Tie-Yan Hong; Wei Zhang; Jian Cheng; Feng Gao; Li-Jie Liu; Xiao-Mao Li; Xue-Mei Wang
Journal:  Int J Nanomedicine       Date:  2009-04-20

10.  Longitudinal bioluminescence imaging of the dynamics of Doxorubicin induced apoptosis.

Authors:  Gang Niu; Lei Zhu; Don N Ho; Fan Zhang; Haokao Gao; Qimeng Quan; Naoki Hida; Takeaki Ozawa; Gang Liu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2013-02-21       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.